What is the goal of the ICMR-funded research at Panjab University?

The research aims to develop novel steroidal drug molecules to treat breast cancer, specifically focusing on overcoming drug resistance.

How will the new breast cancer drug candidates be tested?

The compounds will be tested across multiple cancer cell lines using biological assays and validated in animal models.

What is the significance of Professor Ranju Bansal's research?

Professor Bansal's research focuses on designing steroidal drugs to address resistance in breast cancer treatment, building on her prior success in anti-cancer drug development.

Home / Health / New Hope for Breast Cancer: Drug Resistance Targeted

New Hope for Breast Cancer: Drug Resistance Targeted

13 Feb

•

Summary

Rs 65 lakh research project awarded for novel steroidal drug molecules.
Focus on overcoming drug resistance in breast cancer treatment.
Compounds will be tested on cell lines and animal models.

New Hope for Breast Cancer: Drug Resistance Targeted

A significant research endeavor, backed by a Rs 65 lakh grant from the Indian Council of Medical Research (ICMR), is underway at Panjab University. The project, led by Professor Ranju Bansal, focuses on developing innovative steroidal drug molecules specifically designed to treat breast cancer. A key challenge in breast cancer care is the development of resistance to hormonal therapies, rendering treatments ineffective over time.

This three-year project aims to design and develop steroidal drug candidates that can overcome these resistance mechanisms. The research team will rigorously test potential compounds on various cancer cell lines and validate their potency and efficacy in animal models. Professor Bansal brings extensive experience in anti-cancer drug design, with previous work leading to patented discoveries.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.